Oral Nitrite Synthesis and Post-exercise Hypotension

Sponsor
University of Plymouth (Other)
Overall Status
Completed
CT.gov ID
NCT03904394
Collaborator
(none)
23
1
2
22
1

Study Details

Study Description

Brief Summary

Exercise is probably the most effective approach to reduce blood pressure. In fact, a single bout of exercise induces a physiological response known as Post-Exercise Hypotension (PEH) where a prolonged decrease in resting blood pressure occurs in the minutes and hours after exercise. However, it is not fully understood how this response triggers. Recent evidence suggests that oral bacteria may play a key role in blood pressure control by enhancing nitrite, and then nitric oxide (NO) bioavailability under resting conditions in humans. However, no previous study has investigated whether this is a key mechanism involve in PEH. Thus, the main aim of this study was to investigate if the oral nitrate/nitrite pathway is a key regulator of PEH and vasodilation in healthy humans.

Condition or Disease Intervention/Treatment Phase
  • Other: Exercise
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
The Impact of Nitrate-reducing Capacity of Oral Bacteria on Post-exercise Hypotension in Healthy Individuals.
Actual Study Start Date :
May 9, 2017
Actual Primary Completion Date :
Apr 20, 2018
Actual Study Completion Date :
Mar 11, 2019

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo Mouthwash

Other: Exercise
Four sets of 7 minutes at 65% of VO2peak interspersed with 3 min of passive recovery

Active Comparator: Antibacterial Mouthwash

Other: Exercise
Four sets of 7 minutes at 65% of VO2peak interspersed with 3 min of passive recovery

Outcome Measures

Primary Outcome Measures

  1. Change in blood pressure after exercise [Baseline and 1 hour and 2 hours after exercise]

    Blood pressure was measured before and at 1 hour and 2hours after exercise using an electronic sphygmomanometer (ProBP 3400, Welch Allyn). The second and third readings will be averaged to determine mean blood pressure.

Secondary Outcome Measures

  1. Change in reactive hyperaemia [Baseline and 1 hour and 2 hours after exercise]

    Tissue oxygenation index (TOI) were recorded on the left forearm (extensor digitorum) using a NIRS system (NIRO-200NX, Hamamatsu) before exercise and 2 hours after exercise. After baseline measurements (2 minutes), an automatic pneumatic cuff (Hokanson E-20 AG101) was inflated ~5cm above the elbow for 5 minutes to an occlusion pressure of 200 mmHg. Then, inflation of the cuff was rapidly released (< 1 second) and the NIRS measurements were continuously monitored for 5 minutes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Blood pressure (SBP < 130 mmHg; DBP < 90 mmHg) BMI < 30 kg/m2 Age 18 to 50 years old

Exclusion Criteria:

Smoker Hypertension Dyslipidaemia Diabetes Gingivitis or periodontitis Using antibacterial mouthwash or tongue scrapes Taking antibiotics 1 month before the start of the study Females without have irregular menstrual periods

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory of Nutrition, Exercise & Health Plymouth Devon United Kingdom PL4 8AA

Sponsors and Collaborators

  • University of Plymouth

Investigators

  • Principal Investigator: Crai Cutler, MSc, University of Plymouth

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Raul Bescos, Director, University of Plymouth
ClinicalTrials.gov Identifier:
NCT03904394
Other Study ID Numbers:
  • (16/17)-666
First Posted:
Apr 5, 2019
Last Update Posted:
Apr 8, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 8, 2019